ARVN Stock Analysis: Buy, Sell, or Hold?
ARVN - Arvinas, Inc
$8.13
-0.01 (-0.12%)
▼
5d:
+9.57%
30d:
-10.56%
90d:
-20.99%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When ARVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ARVN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ARVN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: ARVN is currently trading at $8.13, which is considered fair relative to its 30-day fair value range of $7.37 to $8.77.
Technical Outlook: Technically, ARVN is in a strong downtrend. The price is approaching resistance at $8.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ARVN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $14.80 (+81.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARVN is in a strong downtrend. The price is approaching resistance at $8.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ARVN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $14.80 (+81.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$7.37 -
$8.77
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 81.8% below Wall St target ($14.80)
Trading Range Analysis
30-Day Trading Range
$7.37 -
$8.77
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.67
(8.3%)
Support & Resistance Levels
Support Level
$6.97
Resistance Level
$8.19
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.36
Wall Street Target
$14.80
(+81.8%)
Revenue Growth (YoY)
-91.7%
Profit Margin
-247.5%
Share & Embed Analysis
Last updated: June 24, 2026 10:33 AM ET
Data refreshes hourly during market hours. Next update: 11:33 AM
Data refreshes hourly during market hours. Next update: 11:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARVN showing a specific setup today?
Insider Activity (6 Months)
1
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Noah Berkowitz
SELL
6435 shares
2026-03-18
Briggs Morrison
BUY
20000 shares
2026-03-06
John G Houston
SELL
35297 shares
2026-02-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 54 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 67 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |
Advanced ARVN Option Strategies
Professional options setups generated by AI based on today's ARVN price and gamma walls.
